Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine Post-AlloHSCT in AML and MDS
NCT01809392Phase 3Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jan 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by First Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01809392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01809392.